Skip to content

Robotic Versus Laparoscopic Right Hemicolectomy With Complete Mesocolic Excision

Robotic Versus Laparoscopic Right Hemicolectomy With Complete Mesocolic Excision: a Retrospective Multicenter Study With Propensity Score Matching

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05457426
Enrollment
382
Registered
2022-07-14
Start date
2022-04-01
Completion date
2022-06-22
Last updated
2022-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oncological Outcomes, Perioperative Outcomes

Keywords

Robot, Right hemicolectomy, Complete mesocolic excision

Brief summary

the investigators performed a retrospective multicenter propensity score matching study. From July 2016 to July 2021, 382 consecutive patients from different Chinese surgical departments were available for inclusion out of an initial cohort of 412, who underwent robotic or laparoscopic right hemicolectomy with CME.

Detailed description

All consecutive patients who underwent robotic or laparoscopic right hemicolectomy with CME from July 2016 to July 2021 at three Chinese surgical departments (Department of General Surgery, Army Medical Center, Chongqing;Department of Colorectum, Chongqing University Three Gorges Hospital, Chongqing;Department of Colorectum, the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou) were included in the study. A retrospective review of multicenter institutional database was conducted. The Da Vinci Surgical System (Intuitive Surgical, Sunnyvale, CA, USA) has been employed since 2016 in three centers. From July 2016 to July 2021, an initial cohort of 412 consecutive patients underwent robotic or laparoscopic right hemicolectomy with CME in three departments. With 30 cases meeting the exclusion criteria, 382 cases, including 204 males and 178 females, were available for inclusion. Of these, 149 cases by robotic right hemicolectomy with CME were classified as the robotic group, while the other 233 cases by laparoscopic right hemicolectomy with CME as the laparoscopic group.

Interventions

PROCEDURErobotic right hemicolectomy with CME

The distribution of trocars was placed according to the position of Intuitive Surgical Inc. for robotic colectomy. The robot was set to come and dock from theright shoulder of the patient. Three robotic 8-mm trocars (R1, R2 and R3) and two 12-mm trocars (camera and assistant port) were used for the robotic procedure. One working arm carrying a monopolar cautery hook for dissection was located in the left upper quadrant port (R1). The other two working arms carried bipolar forceps in the suprapubic port (R3), and Cadiere's fenestrated forceps in the right lower quadrant port (R2) that was used to keep the superior mesenteric axis in traction. After gentle cephalad traction on the transversemesocolon with the grasp in R2, the assistant grasped the ileocecal valve through the assistant port to put the ileocolic vascular pedicle on tension and the ileocolic vessels were identified and lifted up with R3.

Sponsors

Third Military Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Adenocarcinoma was confirmed by preoperative colonoscopy and it was located in the right colon. 2. Preoperative enhanced abdominal CT examination showed no invasion of abdominal wall or adjacent organs. 3. The patient underwent robotic or laparoscopic right hemicolectomy with CME.

Exclusion criteria

1. Multiple primary colorectal tumors 2. Metastasis to abdominal 3. Pelvic or distant organs 4. Accompanied with bowel obstruction or perforation 5. Neuroendocrine tumors 6. Lymphomas 7. Other malignant tumors.

Design outcomes

Primary

MeasureTime frameDescription
diseasefree survival(months)until July 2021Collect outcomes of follow-up and use Kaplan-Meier survival analysis to analyze it.
overall survival(months)until July 2021Collect outcomes of follow-up and use Kaplan-Meier survival analysis to analyze it.

Secondary

MeasureTime frameDescription
estimated blood lossduring the surgerythe mililiter of the blood loss during surgery
oral retakeup to 30 days after surgerythe patients begin to recover intake
time to return to bowel functionup to 30 days after surgerythe patients begin to recover bowel function
length of stayup to 30 days after surgerythe days of hospital stay
conversion ratesduring the surgerythe incidence of a conversion to open surgery
complicationsup to 30 days after surgeryPostoperative complications, such as ileus, anastomotic leak, small intestinal obstruction, bleeding and so on. Number of Participants with complications will be recorded.
harvest lymph nodesup to 7 days after surgerythe number of harvest lymph nodes in postoperative pathological report
lymph node metastasisup to 7 days after surgerythe number of patients with lymph node metastasis
total hospitalization costup to 30 days after surgerythe total cost of this treatment by RMB
operative timeduring the surgerythe miniutes of surgery from skin to skin

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026